Profile of Patients with Esophageal Cancer Diagnosed Between 2001 and 2010 in Brazil

Authors

  • Ariane Igreja Buccos Marinho Cruz Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0002-6196-575X
  • Luis Felipe Ribeiro Pinto Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0001-5509-1008
  • Luiz Claudio Santos Thuler Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0003-2550-6537
  • Anke Bergmann Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0002-1972-8777

DOI:

https://doi.org/10.32635/2176-9745.RBC.2018v64n4.195

Keywords:

Esophageal Neoplasms, Risk Factors, Neoplasm Staging, Brazil, Electronic Health Records

Abstract

Introduction: Esophageal cancer is the third most common neoplasm of the digestive tract and presents poor prognosis when diagnosed in advanced stages of the disease. Objective: To describe the socio-demographic, clinical and treatment characteristics of patients diagnosed with esophageal cancer in Brazil, from 2001 to 2010. Method: A cross-sectional study of patients with esophageal cancer registered between 2001 and 2010 in Hospital-based registries. Socio-demographic, clinical and treatment variables were analyzed. Descriptive analysis was performed using mean and standard deviation for continuous variables, and absolute and relative frequency for categorical variables. Results: A total of 24,204 patients were included, with a mean age of 60.8 years (± 11.5). The majority of the population was male (78.3%), with a low level of schooling (75.2%), alcoholics (62.9%), smokers (76.0%), and had an advanced stage of diagnosis (41.3% in clinical stage III and 26.9% in stage IV), the topographic group being the most prevalent was in the esophagus upper and middle (76.4%). 12.7% of the patients were not submitted to any cancer treatment. The most frequent treatments were the combination of radiotherapy and chemotherapy (25.6%), and treatment alone with radiotherapy (21.9%). At the end of the first cancer treatment, 10.7% had no evidence of disease, 8.4% had partial remission, 26.6% had a stable disease, and the remaining patients had progression or death (54.4%). Conclusion: In Brazil, the cases diagnosed for esophageal cancer are mostly diagnosed in advanced stages of the disease, which represents greater therapeutic aggressiveness and worse response to treatment.

Downloads

Published

2018-12-31

How to Cite

1.
Cruz AIBM, Pinto LFR, Thuler LCS, Bergmann A. Profile of Patients with Esophageal Cancer Diagnosed Between 2001 and 2010 in Brazil. Rev. Bras. Cancerol. [Internet]. 2018 Dec. 31 [cited 2025 Apr. 3];64(4):471-7. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/195

Issue

Section

ORIGINAL ARTICLE

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >>